These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15072706)

  • 21. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole.
    Yang J; Zhong J; Zhou LZ; Hong T; Xiao XH; Wen GB
    Intern Med; 2012; 51(16):2189-92. PubMed ID: 22892501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methimazole-induced aplastic anemia].
    Mechelli S; Bolognesi S; Siuti E; Stefanelli A; Castiglioni MG
    Recenti Prog Med; 1999 Sep; 90(9):470-2. PubMed ID: 10544668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
    Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
    Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aplastic anaemia caused by thiamazole--a case report].
    Milosević R; Bogunović M; Antonijević N
    Srp Arh Celok Lek; 2004; 132(5-6):171-3. PubMed ID: 15493589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of hypersensitivity syndrome induced by methimazole for Graves' disease.
    Ozaki N; Miura Y; Sakakibara A; Oiso Y
    Thyroid; 2005 Dec; 15(12):1333-6. PubMed ID: 16405404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of drug (methimazole)-induced secondary aplastic anemia].
    Kobayashi T; Ishiguro A; Andoh O; Tsuji K; Naganuma K; Yagi Y; Nakahata T; Akabane T
    Rinsho Ketsueki; 1987 Sep; 28(9):1587-92. PubMed ID: 3437520
    [No Abstract]   [Full Text] [Related]  

  • 31. Methimazole-induced acute pancreatitis: a case report.
    Kikuchi I; Miyata N; Yoshimura Y; Miyamoto K; Tachikawa N
    Clin J Gastroenterol; 2019 Jun; 12(3):239-242. PubMed ID: 30474825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complete remission of essential thrombocythemia after recovery from severe bone marrow aplasia induced by busulfan treatment].
    Yamamoto K; Nagata K; Hamaguchi H
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):365-9. PubMed ID: 9051142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Agranulocytosis/granulocytopenia after long-term use of thiamazole].
    Stellingwerf M; Jellema WT; Eland IA; Wakelkamp IM
    Ned Tijdschr Geneeskd; 2011; 155():A2430. PubMed ID: 21262008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone marrow aplasia caused by synthetic antithyroid agents].
    Fernández Pérez JC; González Rodríguez A; Colunga Argüelles D; Abad Requejo P; Cárcaba Fernández V
    An Med Interna; 2004 Jan; 21(1):48-9. PubMed ID: 15195492
    [No Abstract]   [Full Text] [Related]  

  • 35. Pancytopenia in untreated patients with Graves' disease.
    Lima CS; Zantut Wittmann DE; Castro V; Tambascia MA; Lorand-Metze I; Saad ST; Costa FF
    Thyroid; 2006 Apr; 16(4):403-9. PubMed ID: 16646688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Massive plasmacytosis with severe marrow suppression induced by methimazole in Graves' disease patients: case report and literature review.
    Xiao F; Li C; You L; Qian W; Wei J
    Int J Clin Exp Med; 2014; 7(10):3605-8. PubMed ID: 25419407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methimazole-induced aplastic anemia?
    Bishara J; Dux S; Pitlik SV
    Ann Pharmacother; 1996 Jun; 30(6):684. PubMed ID: 8792961
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis.
    Yang J; Zhong J; Xiao XH; Zhou LZ; Chen YJ; Liu JH; Cao RX; Wen GB
    Endocr J; 2013; 60(2):185-9. PubMed ID: 23117149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.